Skip to main content
Loading

Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies

25 Sep 2025
Immunogenicity Immune Regulation Translational Immunology Immune Biomarkers Clinical Development
Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies
We will explore some of the cutting-edge advancements in our antibody discovery and engineering approaches to engineer unique properties in next generation therapeutic antibodies, including an introduction to AvantGen’s AIMED™ Platform. With the aim to enhance specificity, potency, and to expand the therapeutic index, we will discuss how they hold the promise to significantly improve patient outcomes.
Industry Expert
Jordon Wang, Chief Operating Officer - Avantgen